Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Vomiting × Pantoprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Zollinger-Ellison Syndrome 1 Vomiting 1 Prostatic Neoplasms 1 Pancreatitis 1 Pancreatic Neoplasms 1 Ototoxicity 1 Osteosarcoma 1 Neoplasm Metastasis 1 Gastrinoma 1 Duodenal Neoplasms 1 Breast Neoplasms 1

Interventions

Aprepitant 13 Dexamethasone 11 Palonosetron 10 Ondansetron 9 fosaprepitant 4 Olanzapine 4 Granisetron 3 Calcium Dobesilate 3 ramosetron 2 netupitant 2 Tropisetron 2 Radiotherapy 2 Fluorouracil 2 rolapitant 1 netupitant, palosentron drug combination 1 ginger extract 1 dolasetron 1 casopitant 1 Therapeutics 1 Serotonin 5-HT3 Receptor Antagonists 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation 1 Pantoprazole 1 Paclitaxel 1 Oxaliplatin 1 Octreotide 1 Megestrol Acetate 1 Megestrol 1 Lorazepam 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948477 2022-05-25

PantoCIN

University of Auckland, New Zealand

Phase 2 Completed

Breast Neoplasms, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡